Randomized Study of Botulinum Toxin Type A for Achalasia
Completed
University of Texas
N/A
1997-01-01
OBJECTIVES: I. Compare the efficacy of two doses of botulinum toxin in the treatment of
achalasia.
II. Compare the safety of these two doses in these patients.
Amlodipine Plus Botulinum Toxin for Focal Dystonia
Completed
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 2
2001-04-01
Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of
botulinum toxin injections in the treatment of focal dystonia.
Study Population: 20 patients with cervical dystonia
Design: Double-bind, placebo-controlled clinical trail.
Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia scale,
NINDS subjective patient rating scale), and hand grip strength. For healthy volunteers:
Amplitude of EDB MEP.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
